Cargando…
Low molecular weight fucoidan inhibits hepatocarcinogenesis and nonalcoholic fatty liver disease in zebrafish via ASGR/STAT3/HNF4A signaling
BACKGROUND: Hepatocellular carcinoma ranks fourth in cancer‐related mortality currently lacks effective therapeutics. Fucoidan is sulfated polysaccharide that is mainly found in brown seaweeds. In this study, we investigated the effects and mechanisms of low molecular weight fucoidan (i.e. oligo‐fuc...
Autores principales: | Wu, Szu‐Yuan, Yang, Wan‐Yu, Cheng, Chun‐Chia, Lin, Kuan‐Hao, Sampurna, Bonifasius Putera, Chan, Suat‐Ming, Yuh, Chiou‐Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752165/ https://www.ncbi.nlm.nih.gov/pubmed/33377648 http://dx.doi.org/10.1002/ctm2.252 |
Ejemplares similares
-
A Novel AURKA Mutant-Induced Early-Onset Severe Hepatocarcinogenesis Greater than Wild-Type via Activating Different Pathways in Zebrafish
por: Su, Zhong-Liang, et al.
Publicado: (2019) -
Transcriptomically Revealed Oligo-Fucoidan Enhances the Immune System and Protects Hepatocytes via the ASGPR/STAT3/HNF4A Axis
por: Cheng, Chun-Chia, et al.
Publicado: (2020) -
l-Carnitine ameliorates congenital myopathy in a tropomyosin 3 de novo mutation transgenic zebrafish
por: Hsu, Po-Jui, et al.
Publicado: (2021) -
Low Molecular Weight Fucoidan Prevents Radiation-Induced Fibrosis and Secondary Tumors in a Zebrafish Model
por: Wu, Szu-Yuan, et al.
Publicado: (2020) -
Identification of Novel Anti-Liver Cancer Small Molecules with Better Therapeutic Index Than Sorafenib via Zebrafish Drug Screening Platform
por: Lin, Han-Syuan, et al.
Publicado: (2019)